{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:55:33Z","timestamp":1767135333255,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd001507.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T00:00:00Z","timestamp":1370390400000}}],"reference-count":19,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001507.pub3","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T08:14:18Z","timestamp":1370420058000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tyrosine supplementation for phenylketonuria"],"prefix":"10.1002","author":[{"given":"Diana","family":"Webster","sequence":"first","affiliation":[{"name":"Bristol Royal Hospital for Children; Nutrition and Dietetic Department; Upper Maudlin Street Bristol UK BS2 8BJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Wildgoose","sequence":"additional","affiliation":[{"name":"Bradford Royal Infirmary; Physio Corridor, Level 1; Duckworth Lane Bradford UK BD9 6RJ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,6,5]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD001507.pub3-BIB0001|cit1","first-page":"1261","article-title":"Cognition and tyrosine supplementation among school-aged children with phenylketonuria","volume":"146","author":"Mazzocco","year":"1992","journal-title":"American Journal of Diseases of Children"},{"issue":"6","key":"10.1002\/14651858.CD001507.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0022-3476(95)70031-5","article-title":"Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria","volume":"127","author":"Pietz","year":"1995","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD001507.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/adc.78.2.116","article-title":"Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria","volume":"78","author":"Smith","year":"1998","journal-title":"Archives of Disease in Childhood"},{"issue":"9","key":"10.1002\/14651858.CD001507.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1651-2227.2005.tb02078.x","article-title":"Behavioural effects of phenylalanine-free amino acid tablet supplementation in intellectually disabled adults with untreated phenylketonuria","volume":"94","author":"Kalkanoglu","year":"2005","journal-title":"Acta Paediatrica"},{"issue":"4","key":"10.1002\/14651858.CD001507.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1651-2227.1987.tb10521.x","article-title":"Increased vigilance and dopomine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria","volume":"76","author":"Lou","year":"1987","journal-title":"Acta Paediatrica Scandanavia"},{"issue":"3","key":"10.1002\/14651858.CD001507.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF00441411","article-title":"Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine","volume":"148","author":"Lykkelund","year":"1988","journal-title":"European Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001507.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/adc.88.4.327","article-title":"Are tablets a practical source of protein substitute in phenylketonuria?","volume":"88","author":"MacDonald","year":"2003","journal-title":"Archives of Disease in Childhood"},{"issue":"6","key":"10.1002\/14651858.CD001507.pub3-BIB0008|cit8","first-page":"417","article-title":"Case studies of the effect of tyrosine administration in children with phenylketonuria on cognitive processes","volume":"204","author":"Wasser","year":"1992","journal-title":"Klinische Padiatrie"},{"issue":"2","key":"10.1002\/14651858.CD001507.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1440-1754.1997.tb01031.x","article-title":"Tyrosine supplementation in phenylketonuria [letter]","volume":"33","author":"Lines","year":"1997","journal-title":"Journal of Paediatrics and Child Health"},{"key":"10.1002\/14651858.CD001507.pub3-BIB0010|cit10","first-page":"177","article-title":"Disorders of amino acid metabolism, organic acidaemias and uria cycle defects","volume-title":"Clinical Paediatric Dietetics","author":"Dixon","year":"1994"},{"issue":"1","key":"10.1002\/14651858.CD001507.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analysis involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD001507.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00491918","article-title":"Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents","volume":"144","author":"Lou","year":"1985","journal-title":"European Journal of Pediatrics"},{"issue":"6870","key":"10.1002\/14651858.CD001507.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/bmj.306.6870.115","article-title":"Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story","volume":"306","author":"Medical Research Council Working Party on Phenylketonuria","year":"1993","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD001507.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/adc.68.3.426","article-title":"Recommendations on the dietary management of phenylketonuria","volume":"68","author":"Medical Research Council Working Party on Phenylketonuria","year":"1993","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1002\/14651858.CD001507.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneur.1973.00490190063008","article-title":"Saturation of blood brain barrier transport of amino acids in phenylketonuria","volume":"28","author":"Oldendorf","year":"1973","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD001507.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1542\/peds.20.2.290","article-title":"The variability and manifestations of untreated patients with phenylketonuria (phenylpyruvic aciduria)","volume":"20","author":"Paine","year":"1957","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD001507.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD001507.pub3-BIB0018|cit18","first-page":"1015","article-title":"The hyperphenylalaninaemias","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Scriver","year":"1995"},{"issue":"8","key":"10.1002\/14651858.CD001507.pub3-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001507.pub2","article-title":"Tyrosine supplementation for phenylketonuria","author":"Webster","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001507.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD001507.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T21:32:48Z","timestamp":1645651968000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001507.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,5]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001507.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,5]]}}}